- Duette, Gabriel;
- Hiener, Bonnie;
- Morgan, Hannah;
- Mazur, Fernando G;
- Mathivanan, Vennila;
- Horsburgh, Bethany A;
- Fisher, Katie;
- Tong, Orion;
- Lee, Eunok;
- Ahn, Haelee;
- Shaik, Ansari;
- Fromentin, Rémi;
- Hoh, Rebecca;
- Bacchus-Souffan, Charline;
- Nasr, Najla;
- Cunningham, Anthony;
- Hunt, Peter W;
- Chomont, Nicolas;
- Turville, Stuart G;
- Deeks, Steven G;
- Kelleher, Anthony D;
- Schlub, Timothy E;
- Palmer, Sarah
Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of CD4+ T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory CD4+ T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory CD4+ T cells when compared with naive, central, and transitional memory CD4+ T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.